Stem cell therapy for ischemic heart disease.
Stem cell transplantation has emerged as a novel treatment option for ischemic heart disease. Different cell types have been utilized and the recent development of induced pluripotent stem cells has generated tremendous excitement in the regenerative field. Bone marrow-derived multipotent progenitor cell transplantation in preclinical large animal models of postinfarction left ventricular remodeling has demonstrated long-term functional and bioenergetic improvement. These beneficial effects are observed despite no significant engraftment of bone marrow cells in the myocardium and even lower differentiation of these cells into cardiomyocytes. It is thought to be related to the paracrine effect of these stem cells, which secrete factors that lead to long-term gene expression changes in the host myocardium, thereby promoting neovascularization, inhibiting apoptosis, and stimulating resident cardiac progenitor cells. Future studies are warranted to examine the changes in the recipient myocardium after stem cell transplantation and to investigate the signaling pathways involved in these effects.
Jameel
Mohammad Nurulqadr
MN
Department of Medicine, University of Minnesota Medical School , Minneapolis, Minnesota 55455, USA.
Zhang
Jianyi
J
D064987:Cell- and Tissue-Based Therapy / Q000379:methods*; D006801:Humans; D017202:Myocardial Ischemia / Q000628:therapy*; D015398:Signal Transduction; D033581:Stem Cell Transplantation / Q000379:methods*